Before we witness the stabilization of economic growth in Europe and North America, Asia Pacific is estimated to bounce back progressively with countries such as China, India, South Korea and Japan witnessing more opportunities to recover from the losses sustained during COVID-19.
Being the biggest market in Eastern Europe, Russia is estimated to take the lowest hit, offering a sigh of relief to the businesses operating in the country. Whereas, GCC is estimated to observe low investments due to the sliding prices of crude oil.
We evaluate the strategies and commitment of the Giant Players in the market towards creating products and services that customers value and rely on.
In an attempt to control and eliminate the surge of coronavirus cases and meet the demand for required medical devices along with providing efficient medical services, there is a drastic shift of investments from authoritative bodies towards the healthcare sector. Where the aftermath of this pandemic may take years to be measured, Research Nester estimates notable expansion of e-health, gaming, and media and entertainment industries till the whole situation is contained and the plan of action for the recovery process is determined. There is an estimated probability of the growth in businesses going back a year if the condition is controlled in the next 2-3 months. Request Insights
IN THE NEWSMarch 2020: Avery Dennison Corporation, on March 2, 2020, announced that it has completely acquired Smartrac’s Transponder business for development and manufacture of RFID products, in a deal of around USD 226.58 million.
August 2020: CCL Healthcare joined hands with DoseID Consortium to expand its scope to the use of radio-frequency identification (RFID) technology in the healthcare sector.
The global anti-counterfeit pharmaceutical packaging market is anticipated to gain a sizeable revenue and witness a significant CAGR during the forecast period, i.e., 2021 – 2029. This can be accounted to the increasing number of counterfeit products and growing demand for well-protected pharmaceutical drug packaging. According to the WHO, 1 out of every 10 medical products in developing countries is counterfeited or substandard. Amongst all the regions in the world, 42% of the reports came from Africa. Along with these, rising emphasis of manufacturers to safeguard their brand identities and stringent government regulations to prevent illegal drug channeling are also expected to drive growth to the market in the near future. Furthermore, development of innovative technologies for identification and authentication of medicines is estimated to provide impetus to the market in the coming years.
The anti-counterfeit pharmaceutical packaging market can be segmented by technology into mass encoding, security printing & graphics, holograms, RFID, and security ink coatings. Out of these, the mass encoding segment is projected to hold a significant market share during the forecast period, owing to its excellent product tracking solution in several nodes of the supply chain management. However, the segment for RFID is estimated to register highest growth by the end of 2029, which can be attributed to the better tracking features and product security of this technology. Additionally, on the basis of feature, the segments for covert & overt features are evaluated to grow with a notable CAGR during the forecast period. This can be credited to the increasing adoption of covert & overt systems as they are able to offer authenticated packaging in the form of a visual representation or any other comprehensive method which is extremely hard to copy without a particular detection device.
On the basis of regional analysis, the anti-counterfeit pharmaceutical packaging market is segmented into five major regions, including North America, Europe, Asia Pacific, Latin America and the Middle East & Africa. The North American region is predicted to account for the largest share in the market by both value and volume during the forecast period, owing to the rising focus on promoting the use of sustainable anti-counterfeit packaging alternatives and the presence of the majority of key players. However, the Asia Pacific is calculated to record immense growth during the forecast period on the back of the growing realization among consumers that has led to them to become more aware regarding what they are buying before consumption, which in turn is also estimated to increase the demand of these packaging in this region. In addition, rising adoption of security technologies for medicines in China alone is also expected to drive market growth in the region. CLICK TO DOWNLOAD SAMPLE REPORT
The anti-counterfeiting pharmaceutical packaging market is further classified on the basis of region as follows:
Our in-depth analysis of the anti-counterfeit pharmaceutical packaging market includes the following segments:
FREQUENTLY ASKED QUESTIONS
Strict regulatory framework associated with anti-counterfeit packaging and development of innovative packaging technologies are considered to be the major market growth drivers.
The market is anticipated to attain a significant CAGR over the forecast period, i.e., 2021 – 2029.
Costly setup of anti-counterfeit pharmaceutical packaging is estimated to hamper the market growth.
Asia Pacific will provide more business opportunities on the back of growing awareness regarding the benefits of anti-counterfeit packaging.
The major players in the market are Avery Dennison Corporation, CCL Industries Inc., DuPont de Nemours, Inc., AlpVision S.A, and others.
The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.
The market is segmented by technology, feature, and by region.
The RIFD segment is anticipated to hold largest market size and is estimated to grow at a notable CAGR over the forecast period and display significant growth opportunities.
Related Reports
Disclaimer | Privacy Policy | Terms & Conditions
Copyright © 2021 Research Nester. All Rights Reserved
